Kawakita T, Sekiya T, Kameda Y, Nomura N, et al. ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4(+) and CD8(+) T-cell responses and neutralizing antibody induction. J Virol 2025 Apr 15:e0229024. doi: 10.1128/jvi.02290.
PMID: 40231823